| Literature DB >> 19432955 |
Oliver C Jann1, Annemarie King, Nestor Lopez Corrales, Susan I Anderson, Kirsty Jensen, Tahar Ait-Ali, Haizhou Tang, Chunhua Wu, Noelle E Cockett, Alan L Archibald, Elizabeth J Glass.
Abstract
BACKGROUND: Over the last decade, several studies have identified quantitative trait loci (QTL) affecting variation of immune related traits in mammals. Recent studies in humans and mice suggest that part of this variation may be caused by polymorphisms in genes involved in Toll-like receptor (TLR) signalling. In this project, we used a comparative approach to investigate the importance of TLR-related genes in comparison with other immunologically relevant genes for resistance traits in five species by associating their genomic location with previously published immune-related QTL regions.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19432955 PMCID: PMC2689273 DOI: 10.1186/1471-2164-10-216
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Location of TLR and related signalling genes on the porcine FPC map compared to the porcine RH map
| 8 | 30.3 | 8 | 8 | 9.0 | |||
| 8 | 83.6 | 8 | 5.8 | ||||
| 15 | 58.9 | 15 | |||||
| 1 | 284.7 | 1 | SSC1q2.9-q2.13 [ | ||||
| 10 | 14.9 | 10 | |||||
| 8 | 30.3 | 8 | 8 | 13.9 | |||
| X | 9.3 | ||||||
| X | 9.4 | ||||||
| 13 | 39.7 | 13 | 13 | 4.2 | SSC13q2.1-q3.2 [ | ||
| 8 | 30.3 | 8 | 8 | 14.1 | |||
| 15 | 128.6 | 15 | |||||
| X | 133.9 | X | |||||
| 4 | 70.7 | 4 | |||||
| 13 | 29.0 | 13 | 13 | 9.2 | |||
| 2 | 120.8 | ||||||
| 9 | 57.0 | 9 | |||||
| 2 | 22.8 | 2 | |||||
| 6 | 52.8 | 6 | |||||
HTGS: BLAST hits against the high throughput genomic sequence of the pig
Location of TLR and related signalling genes on the virtual sheep genome compared to the ovine RH map
| 6 | 55.5 | 6 | 5.60 | ||
| 17 | 3.7 | 17 | 15.36 | ||
| 26 | 18.6 | 26 | 6.69 | ||
| 2 | 3.7 | 2 | 11.57 | ||
| 12 | 38.7 | 12 | 8.62 | ||
| 6 | 55.5 | 6 | 10.25 | ||
| X | 12.7 | X | 9.36 | ||
| X | 12.7 | X | 9.36 | ||
| 19 | 52.9 | 19 | 14.16 | ||
| 6 | 55.5 | 6 | 13.55 | ||
| 2 | 228.8 | [1] | 3.70 | ||
| X | 96.1 | [unlinked] | 2.47 | ||
| 9 | 67.8 | 9 | 7.26 | ||
| 19 | 10.8 | 19 | 11.07 | ||
| 5 | 23.1 | 5 | 7.50 | ||
| 5 | 43.0 | [7] | 2.97 | ||
| 21 | 25.6 | 21 | 7.49 | ||
| 21 | 47.9 | [21] | 2.49 | ||
| 15 | 62.1 | 15 | 5.38 | ||
| 14 | 78.4 | 14 | 9.31 | ||
Markers marked by [ ] have LOD scores < 5
Comparative localisation of TLR and related signalling molecules
| 8: 30.3 | 6: 55.5 | 6: 60.4 | 7 | 5: 65.3 | 12, 15, 16 | 4: 38.5 | m, g' | |||
| 8: 83.6 | 1 | 17: 3.7 | 17: 4.3 | 3: 83.6 | 12, 13, 17 | 4: 154.8 | a, b, c, d, e | |||
| 15: 58.9 | 26: 18.6 | 27: 17.5 | 8: 46.5 | 12 | 4: 187.2 | |||||
| 1: 284.7 | 2: 3.7 | 8: 112.4 | 4: 66.5 | 18 | 9: 119.5 | f, g, h | ||||
| 10: 24.9 | 12: 38.7 | 16: 23.6 | 10 | 1: 184.9 | 12, 16, 17, 19 | 1: 221.3 | i | |||
| 8: 30.3 | 6: 55.5 | 6: 60.4 | 7 | 5: 65.3 | 12, 15, 16 | 4: 38.5 | m, g' | |||
| X: 9.3 | X: 12.7 | X: 82.1 | X: 163.7 | X: 12.8 | ||||||
| X: 9.4 | X: 12.7 | X: 82.0 | X: 163.7 | X: 12.8 | ||||||
| 13: 39.7 | 19: 52.9 | 22: 49.7 | 9 | 9: 106.1 | 18 | 3: 52.2 | g' | |||
| 8: 30.3 | 6: 55.5 | 6: 60.3 | 7 | n/a: n/a | 4: 38.4 | |||||
| 15: 128.6 | 2: 94.0 | 1: 58.8 | 18, 20 | 2: 201.8 | ||||||
| X: 133.9 | X: 23.5 | X: 71.3 | X: 152.9 | f' | ||||||
| 4: 70.7 | 9: 67.8 | 14: 35.0 | 9' | 1: 16.7 | 17 | 8: 75.1 | ||||
| 13: 29.0 | 19: 10.8 | 22: 11.7 | 10 | 9: 119.2 | 18, 21 | 3: 38.2 | ||||
| 5: 23.1 | 7: 17.9 | 17: 56.4 | 22 | 19: 4.7 | 11 | |||||
| 2: 120.8 | 2 | 10: 3.9 | 18: 46.7 | 12, 23 | 5: 114.9 | |||||
| 9: 57.0 | 21: 25.6 | 29: 31.2 | 9: 35.0 | 14, 23 | 11: 125.7 | g', j, k, m' | ||||
| 21: 47.9 | 29: 44.0 | 7: 149.1 | 24 | 11: 1.3 | ||||||
| 2: 22.8 | 15: 62.1 | 15: 62.1 | 8 | 2: 101.5 | 11: 36.5 | |||||
| 6: 52.8 | 3,4,5, l | 14: 78.4 | 6 | 18: 56.0 | 7' | 7: 52.3 | 13, n | 19: 54.8 | 11 | |
n/a: no functional homologue for TLR10 in mouse,
QTL studies: 1: Stress induced alteration in number of neutrophils [35], 2: Stress induced leukocyte proliferation [35], 3: Small intestinal Escherichia coli [36], 4,5: Anti 0149 Escherichia coli IgG levels/level response [35], 6: Nematodirus FEC1 Average [37], 7: Clinical mastitis [38], 7': Clinical mastitis [39], 8: General disease resistance [40], 9: Somatic cell score [41], 9': Somatic cell score [42], 10: Trypanosoma congolense tolerance [43], 11: Coxsackie virus B3 sensitivity [44], 12: Leishmania resistance [45], 13: Mycobacterium tuberculosis susceptibility [46], 14: Mycobacterium tuberculosis infection severity [47], 15: Listeria monocytogenes resistance [48], 16: Trypanosoma cruzi infection response [49], 17: Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility [50], 18: Borrelia burgdorferi-associated arthritis [51], 19: Plasmodium berghei malaria resistance [52], 20: Susceptibility/immunity to Salmonella typhimurium antigens [53], 21: Plasmodium chabaudi malaria resistance [54], 22: Angiostrongylus costaricensis nematode susceptibility [55], 23: Protection against vaginal Candida albicans infections [56], 24: Determination of interleukin commitment [57]
Association studies: a: Mycobacterium sp. [58], b: Mycobacterium leprae [59], c: Urinary tract infections [60], d: Borrelia burgdorferi [61], e: Treponema pallidum [62], f: Gram-negative infections [63], f': Sepsis [64], g: Plasmodium falciparum [65], g': Plasmodium falciparum [66], h: Bacterial vaginosis [67], i: Legionella pneumophila [68], j: Bacteremia [69], k: Pneumococcia sp. [69], l: Small intestinal Escherichia coli [36], m: Mycobacterium tuberculosis [70], m': Mycobacterium tuberculosis [69], n: Listeria monocytogenes [71]
Figure 1Position of . QTL positions are indicated by bold blue lines. Green boxes indicate the localisation of syntenic blocks conserved between species. Inversions of the gene order are indicated by red arrows. Markers located on the boundaries of the QTLs in mouse (susceptibility to Mycobaterium tuberculosis), human (Coxsackie virus resistance), cattle (susceptibility to clinical mastitis) and sheep (Nematodirus egg count) or the blocks of conserved synteny are indicated in blue. Under the assumption that the indicated QTLs are caused by the same loci, the significant region can be narrowed to two segments with a combined length of less than 7 Mb (brown line in syntenic blocks). Immunologically relevant genes located in these regions are listed in additional file 4: Immunologically relevant genes in regions of conserved synteny surrounding the TLR1 family cluster, MyD88 and IRF3.
Figure 2Position of . QTL positions are indicated by bold blue lines. Green boxes indicate the localisation of syntenic blocks conserved among species. Inversions of the gene order are indicated by red arrows. Loci located on the boundaries of the overlap between the QTL in cattle (Tryanosoma resistance) and in mice (Plasmodium chabaudi malaria) are indicated in blue. Under the assumption that the indicated QTLs are caused by the same loci, the significant region can be narrowed to segments with a combined length of approximately 10 Mb (brown line in syntenic blocks). Immunologically relevant genes located in these regions are listed in additional file 4: Immunologically relevant genes in regions of conserved synteny surrounding the TLR1 family cluster, MyD88 and IRF3.
Figure 3Position of the . QTL positions are indicated by bold blue lines. Green boxes indicate the localisation of the syntenic block conserved between species. Under the assumption that the indicated QTLs are caused by the same loci, the significant region can be narrowed to a segments with a length of approximately 20 Mb (brown line in syntenic blocks). Two loci (GPR125 and YIP7, in blue) limit the overlap of the QTL for susceptibility to clinical mastitis in cattle with the QTL for Listeria monocytogenes susceptibility in mice. Polymorphisms in human TLR6 (red, within the QTL overlap) have been associated with susceptibility to tuberculosis. Immunologically relevant genes located in this region are listed in additional file 4: Immunologically relevant genes in regions of conserved synteny surrounding the TLR1 family cluster, MyD88 and IRF3.
Potential QTL related candidate genes with functional relevance, differential expression in divergent phenotypes, and localization within QTL regions
| 19: 39.5 | 7: 35.0 | 18: 44.5 | humoral immune response | n.a. | n.a. | n.a. | ||
| 19: 40.5 | 7: 31.7 | 18: 45.4 | antimicrobial activity of HAMP derived peptides | n.a. | n.a. | |||
| 19: 40.5 | 7: 31.7 | 18: 45.5 | inhibition of B cell receptor signalling | 2.24*e | n.a. | n.a. | ||
| 19: 41.1 | 7: 31.2 | 18: 46.0 | activation of NK cells | 2.11**e | n.a. | |||
| 19: 53.9 | 7: 52.9 | 18: 55.2 | creation of an adhesion site | n.a. | n.a. | |||
| 19: 54.7 | 7: 52.3 | 18: 55.9 | IgG fragment receptor | 0.73**b | n.a. | n.a. | ||
| 19: 54.9 | 7: 52.3 | 18: 56.0 | activation of IFN-β | 1.22*d | n.a. | |||
| 19: 54.9 | 7: 52.2 | 18: 56.0 | inhibition of viral helicase | n.a. | n.a. | |||
| 3: 33.0 | 9: 114.4 | 22: 7.3 | chemokine receptor | i.s. | n.a. | n.a. | ||
| 3: 38.2 | 9: 119.2 | 22: 11.7 | mediation of signal after TLR-ligand binding | 1.39*d | ||||
| 3: 39.3 | 9: 120.0 | 22: 12.8 | chemokine receptor | 0.54**a | 2.09*c | n.a. | ||
| 3: 39.3 | 9: 120.0 | 22: 12.8 | chemokine receptor | i.s. | n.a. | n.a. | ||
| 3: 42.5 | 9: 121.6 | 22: 15.0 | binding of anti-inflammatory peptide | i.s | n.a. | n.a. | ||
| 3: 42.8 | 9: 121.8 | 22: 15.3 | chemokine receptor | i.s. | 1.53*e | n.a. | n.a. | |
| 4: 38.5 | n.o. | 6: 60.3 | binding of unknown ligand | n.o. | n.o. | 2.40* | 1.71* | |
| 4: 38.5 | 5: 65.3 | 6: 60.4 | binding of ligands derived from gram-positive bacteria | 1.37*c | ||||
| 4: 38.5 | 5: 65.3 | 6: 60.4 | binding of ligands derived from gram-positive bacteria | 0.61*d | ||||
| 4: 39.0 | 5: 65.7 | 6: 60.8 | replication factor C (activator 1) 1, | defence response | 0.50*b | n.a. | ||
human/mouse/cattle: Positions in Mb, only significant values shown, empty cells have been analysed and no significant difference have been found. *: p < 0.05, **: p < 0.01, i.s: signal was evaluated as too faint to call, n.o: no mouse ortholog for TLR10, n.a: not analysed in this study
Gene names: GPI: glucose phosphate isomerase, HAMP: hepcidin antimicrobial peptide, CD22: CD22 molecule, TYROBP: TYRO protein tyrosine kinase binding protein, FUT1: fucosyltransferase 1, FCGRT: IgG Fc fragment receptor transporter alpha chain, IRF3: interferon regulatory factor 3, PRMT1: protein arginine methyltransferase 1, CCR4: chemokine (C-C motif) receptor 4, MYD88: myeloid differentiation primary response gene (88), CX3CR1: chemokine (C-X3-C motif) receptor 1, CCR8: chemokine (C-C motif) receptor 8, VIPR1: vasoactive intestinal peptide receptor 1, CCBP2: chemokine binding protein 2, TLR10: toll-like receptor 10, TLR1: toll-like receptor 1, TLR6: toll-like receptor 6, RFC1: replication factor C (activator 1) 1
Ratios of transcript levels: a: ratio of mean transcript levels of resistant C57BL/6 to susceptible BALB/c mice 3 hours post infection and stimulation with IFN-γ, b: ratio of mean transcript levels of resistant C57BL/6 to susceptible BALB/c mice 3 hours post infection without stimulation with IFN-γ, c: ratio of mean transcript levels of resistant C57BL/6 to susceptible BALB/c mice on day 3 post infection, d: ratio of mean transcript levels of resistant C57BL/6 to susceptible A/J mice on day 9 post infection, e: ratio of mean transcript levels of resistant C57BL/6 to susceptible A/J mice in uninfected animals
Pathogens and references: Y.e: Yersinia enterocolitica [86], T.c: Trypanosoma congolense [85], H.c: Haemonchus contortus [19], T.a: Theileria annulata: transcript level in Holstein/Sahiwal 72 h post infection [20]